Seikagaku Corporation
4548
Rank in Stocks
#16936
Headquartered in Tokyo, Japan, Seikagaku Corporation, established in 1947,... Headquartered in Tokyo, Japan, Seikagaku Corporation, established in 1947, specializes in the global development, manufacturing, and distribution of pharmaceuticals and medical devices, with a core focus on glycoconjugates. The company, which was formerly known as K.K. Seikagaku Kenkyusho until its name change in 1962, operates through two primary segments: Pharmaceuticals and LAL. Its product portfolio encompasses a range of therapeutic and surgical solutions. For joint health, Seikagaku provides intra-articular injections like ARTZ, ARTZ Dispo, VISCO-3, and SUPARTZ FX, designed to enhance joint function. The company also supplies ophthalmic surgical aids such as OPEGAN, OPEGAN Hi, and SHELLGAN, alongside MucoUp for endoscopic mucosal resection. Other notable offerings include Gel-One, a cross-linked hyaluronate hydrogel addressing knee osteoarthritis, and HERNICORE for lumbar disc herniation. Beyond finished products, Seikagaku is a supplier of bulk materials, specifically sodium hyaluronate and sodium chondroitin sulfate, which find application in various pharmaceutical and cosmetic formulations. Furthermore, the company develops and markets specialized endotoxin-detecting reagents, including Pyrochrome, ENDOSPECY, and TOXICOLOR, which are crucial for quality assurance in injectable pharmaceuticals, biological products, medical devices, manufacturing operations, and dialysate water quality. Its offerings also extend to oral care, featuring the KINUSUI Spray mouthwash. Seikagaku maintains a robust development pipeline, with promising candidates such as SI-6603 for lumbar disc herniation, SI-614 (a modified hyaluronate for dry eyes), SI-613 for osteoarthritis, SI-613-ETP targeting enthesopathy, and SI-449, a powdered adhesion barrier.
Share Price
$3.44
Last synced: 2026-11-10
Market Cap
$188.02M
Change (1 day)
1.68%
Change (1 year)
-20.96%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Seikagaku Corporation (4548)
Category
Healthcare
EPS for Seikagaku Corporation (4548)
EPS as of June 2026 TTM: $0.19
According to Seikagaku Corporation's latest financial reports, its current EPS (TTM) is $0.19. At the end of 2025 the company had an EPS of $0.15, a decrease compared to its 2024 EPS of $0.26.
EPS history for Seikagaku Corporation from 2005 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.19 | 28.53% |
| 2025 | $0.15 | -43.94% |
| 2024 | $0.26 | -13.18% |
| 2023 | $0.30 | -44.01% |
| 2022 | $0.54 | -20.13% |
| 2021 | $0.68 | -138.16% |
| 2020 | $-1.79 | -599.05% |
| 2019 | $0.36 | -45.09% |
| 2018 | $0.65 | 130.22% |
| 2017 | $0.28 | -29.77% |
| 2016 | $0.40 | -24.72% |
| 2015 | $0.54 | -33.84% |
| 2014 | $0.81 | 33.14% |
| 2013 | $0.61 | -12.33% |
| 2012 | $0.69 | 33.28% |
| 2011 | $0.52 | -22.70% |
| 2010 | $0.67 | 19.05% |
| 2009 | $0.57 | -23.42% |
| 2008 | $0.74 | 43.04% |
| 2007 | $0.52 | -23.32% |
| 2006 | $0.67 | 15.80% |
| 2005 | $0.58 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | 1,300.41% |
US
|
|
| $4.09 | 2,021.37% |
IE
|
|
| $9.45 | 4,801.45% |
US
|
|
| $2.37 | 1,129.25% |
US
|
|
| $1.77 | 818.05% |
US
|
Questions about Seikagaku Corporation's earnings per share (EPS)
What is Seikagaku Corporation's earnings per share (EPS)?
Seikagaku Corporation's earnings per share (EPS) over the last twelve months is $0.19, as of Jun 2026.
What was Seikagaku Corporation's earnings per share (EPS) in 2025?
In 2025, Seikagaku Corporation's earnings per share (EPS) was $0.15, 42.31% less than in 2024 ($0.26).
How has Seikagaku Corporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Seikagaku Corporation's earnings per share (EPS) was highest in 2021 ($0.68) and lowest in 2020 ($-1.79).
How does Seikagaku Corporation's earnings per share (EPS) compare with similar companies?
Seikagaku Corporation's earnings per share (EPS) ($0.19) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.